DEHYDROEPIANDROSTERONE IN SYSTEMIC LUPUS ERYTHEMATOSUS
- 1 May 2000
- journal article
- review article
- Published by Elsevier in Rheumatic Disease Clinics of North America
- Vol. 26 (2) , 349-362
- https://doi.org/10.1016/s0889-857x(05)70142-3
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- DHEAS as an Effective Vaccine Adjuvant in Elderly HumansAnnals of the New York Academy of Sciences, 1995
- Low serum levels of dehydroepiandrosterone may cause deficient IL-2 production by lymphocytes in patients with systemic lupus erythematosus (SLE)Clinical and Experimental Immunology, 1995
- Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cellsClinical Immunology and Immunopathology, 1991
- Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function.The Journal of Experimental Medicine, 1990
- Regulation of murine lymphokine production in vivo II. Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cellsEuropean Journal of Immunology, 1990
- Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus.Journal of Clinical Investigation, 1982
- Low plasma androgens in women with active or quiescent systemic lupus erythematosusArthritis & Rheumatism, 1982
- Systemic lupus erythematosus and klinefelter's syndromeArthritis & Rheumatism, 1980
- Alterations of estrogen metabolism in systemic lupus erythematosusArthritis & Rheumatism, 1979
- Androgenic Hormones Modulate Autoantibody Responses and Improve Survival in Murine LupusJournal of Clinical Investigation, 1977